Medicis Pharmaceutical Corp. (MRX) Reports In-Line Q2 EPS of 64c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.85 --0%
Revenue Growth %: +19.2%
Financial Fact:
Basic net income (loss) per share - continuing operations: 0.02
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Revenue Growth %: +19.2%
Financial Fact:
Basic net income (loss) per share - continuing operations: 0.02
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q2 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $190.8 million versus the consensus estimate of $188.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marex Group PLC (MRX) PT Raised to $80 at Jefferies
- Ryder System (R) Tops Q2 EPS by 5c ; Offers Guidance
- American Airlines (AAL) Tops Q2 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
